Decima Health has created scientifically developed, clinically proven, patented, natural and safe skincare products that are registered under the Atopis® brand. Founded in 2016 by Dr Iona Weir, a scientist with extensive research experience in New Zealand and overseas in cell biology and biochemistry.
It has created a patented method of developing topical bioactive Over The Counter products utilising a novel process that uses all-natural ingredients. A revolutoinary process as, unlike conventional methods, the final product contains a far higher proportion of plant extracts as is far gentler on the extracts, so boosts activity.
The Atopis® Skincare range launched in 2017, holding global patents for clinically proven skincare that treat common issues like rosacea, acne, pigmentation, skin ageing and eczema. It has grown rapidly with strong international sales through the website and Amazon. In 2019 Atopis® began selling their Atopis® Eczema Therapy cream in the United States after achieving Over The Counter Pharmacy registration. In 2021, Decima will register other Atopis® creams targeting rosacea, acne and psoriasis for sale in the OTC market in the US, as well as expanding the Atopis® range. Atopis® will be releasing OTC creams for the Australian and New Zealand markets in the next 12 months.